Multimorbidity and cardiovascular prevention in primary care: Cohort study in New Zealand

This study investigates the relationship between multimorbidity and the dispensing of dual therapy for cardiovascular disease (CVD) prevention among patients in New Zealand, focusing on different CVD risk strata. The authors found that patients with multimorbidity were more likely to receive and maintain dual therapy across all risk levels, although a significant gap in practice remained for those at high CVD risk. Overall, the findings highlight the complexities of medication management in multimorbid patients and the need for improved adherence to treatment guidelines.